Files
Download Full Text (539 KB)
Contents
- A New Era in Treating Patients Who Have Multiple Myeloma: During the past decade, several novel treatments have extended the median survival time for patients with multiple myeloma from less than 3 years to more than 7 years, and researchers are working to further improve treatment
- Landmark Trial Shows Potential of Low-Dose Computed Tomography for Lung Cancer Screening
- HOUSE CALL: Eating Healthier May Reduce Cancer Risk: Healthy eating habits may also increase energy and heart health
- IN BRIEF: Inotuzumab Ozogamicin Shows Promise for Acute Lymphoblastic Leukemia Treatment
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
7-1-2011
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Wang, Michael; Qazilbash, Muzaffar; Kwak, Larry, 1959-; June, Carl; Munden, Reginald; Bevers, Therese; Kantarjian, Hagop, 1952-; Eapen, George; Multiple Myeloma; Antineoplastic Agents; Clinical Trials as Topic; Stem Cell Transplantation; Tomography, Spiral Computed; Lung Neoplasms -- diagnostic imaging; Mass Chest X-Ray; Radiography; Smokers; Ex-Smokers; Diet, Healthy; Dietary Fiber; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Inotuzumab Ozogamicin.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Newberry, Kate and Munch, Joe, "OncoLog, Volume 56, Number 07, July 2011" (2011). OncoLog MD Anderson's Report to Physicians (All issues). 216.
https://openworks.mdanderson.org/oncolog/216
Conditions Governing Access
Open
